Pictured: Carol Lee
Q&A
By Memorial Sloan-Kettering  |  Wednesday, October 10, 2012

During Breast Cancer Awareness Month, Dr. Lee discusses mammography, breast MRI, and breast ultrasound.

Pictured: Filippo Giancotti
In the Lab
By Media Staff  |  Friday, August 24, 2012

A new Memorial Sloan-Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs.

Pictured: Tari King
Video
By Memorial Sloan-Kettering  |  Wednesday, August 15, 2012

Dr. King talks about her research investigating why certain women develop breast cancer and about the long-term relationships she maintains with her patients.

Pictured: Babak Mehrara
Video
By Memorial Sloan-Kettering  |  Wednesday, August 8, 2012

Dr. Mehrara talks about the expertise of Memorial Sloan-Kettering plastic surgeons and how patients with breast cancer and head and neck cancer benefit from recent advances in reconstructive surgery.

Pictured: Joan Massagué
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Friday, July 6, 2012

A team of investigators from Memorial Sloan-Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.

Pictured: Monica Morrow
Video
By Memorial Sloan-Kettering  |  Monday, June 25, 2012

Dr. Morrow, Chief of Memorial Sloan-Kettering’s Breast Surgical Service, discusses how our patients with breast cancer are cared for by a true team of experts in every aspect of treatment and recovery.

Pictured: Chaya Moskowitz
In the Clinic
By Media Staff  |  Monday, June 4, 2012

A new study confirms that female childhood cancer survivors who were treated with radiation to the chest have a high risk of developing breast cancer at a young age – a risk that is comparable to that of women who have mutations in BRCA1 or BRCA2 genes.

Video
By Memorial Sloan-Kettering  |  Tuesday, May 29, 2012

Dr. Pusic, a plastic surgeon specializing in breast reconstruction, talks about advances in reconstructive surgery techniques and in measuring quality of life for patients after surgery.

Pictured: Kimberly Van Zee
Video
By Memorial Sloan-Kettering  |  Friday, April 27, 2012

Dr. Van Zee discusses the personalized care delivered by a multidisciplinary team of breast cancer experts at Memorial Sloan-Kettering.

Pictured: Monica Morrow
Honor
By Memorial Sloan-Kettering  |  Wednesday, March 21, 2012

Dr. Morrow is the first surgeon and the first person from Memorial Sloan-Kettering to receive the American Society of Clinical Oncology’s award, which recognizes breast cancer researchers who are also excellent mentors.

Pictured: Elizabeth Morris
In the O.R.
By Esther Napolitano, BS and Allyson Collins, MS
Friday, March 16, 2012

Memorial Sloan-Kettering is the first and only hospital in New York, New Jersey, and Connecticut to offer a new, more patient-friendly approach for doctors to precisely pinpoint and remove small breast cancers.

Pictured: Monica Morrow
Perspective
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, January 31, 2012

Breast Surgical Service Chief Monica Morrow provides perspective on assessing the quality of surgical breast cancer treatment in an editorial in the February 1 issue of the Journal of the American Medical Association.

Pictured: Clifford Hudis
Honor
By Memorial Sloan-Kettering  |  Wednesday, December 7, 2011

Memorial Sloan-Kettering medical oncologist Clifford A. Hudis has been elected President of the American Society of Clinical Oncology, the world’s leading professional organization representing more than 30,000 physicians who care for people with cancer.

Pictured: Breast tumor treated with paclitaxel
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, December 2, 2011

Recent findings by Memorial Sloan-Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.

In the News
By Media Staff  |  Wednesday, November 23, 2011

Chief of Thoracic Oncology Mark Kris offers his perspective on a promising new tactic for treating lung and other cancers in this story from CBS Evening News with Scott Pelley. The strategy tailors cancer treatment to each individual patient.

Center News

Subscribe to Our E-newsletter

Get the latest information about cancer care.